THE Health Department has opened public consultation on the draft report to the Pharmaceutical Benefits Advisory Committee on the Post-market Review of ezetimibe.
The report looks at the cost-effectiveness of PBS-listed ezetimibe, with submissions set to close at 5pm on Fri 10 Feb.
The draft report and forms for responses are now available for download at www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jan 17
